Dr. Tee SP graduated from University of Malaya with Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1982. He then performed his specialization training in O&G at Seremban General Hospital, University Kebangsaan Malaysia and finally at John Radcliffe Hospital, University of Oxford and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 1989 and later as a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG).
His passion in assisted reproductive technology and fertility treatment led him to pursue his training locally and in National University of Singapore. He qualified with postgraduate Diploma in Reproductive Medicine from the National Population & Family Development Board, Malaysia (LPPKN) in collaboration with Johns Hopkins’ Programme for international Education in O&G, Bachelor of Science in Computing (Hons) from University of Portsmouth, UK and Master of Business Administration from University Tunku Abdul Rahman, Malaysia.
He is one of the pioneer fertility specialists in Malaysia and established Metro IVF Centre in Klang in 1999 and the first IVF pregnancy was delivered in 2000. In 2008, Dr. Tee is one of the key initiators for IVF collaboration between private and public health institutions including Hospital Tengku Ampuan Rahimah, (Metro HTAR IVF Shared Care Programme) and with UiTM (Metro UiTM Private Specialist Centre IVF Shared Care Programme).
With over 20 years of experience in IVF, Dr. Tee has led Metro IVF and it’s group of medical professionals in achieving internationally recognised success rates. The group has since expanded to 7 branches nationwide and was publicly listed in February 2018 on Bursa Malaysia.
Dr. Tee is presently the fertility specialist at Metro IVF and clinical assistant professor at Faculty of Health Science & Medicine at University of Tunku Abdul Rahman (UTAR) and also the treasure and president elect of the Malaysian Society for Assisted Reproductive Technology (MSART).
Dr. Tee SP graduated from University of Malaya with Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1982. He then performed his specialization training in O&G at Seremban General Hospital, University Kebangsaan Malaysia and finally at John Radcliffe Hospital, University of Oxford and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 1989 and later as a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG).
His passion in assisted reproductive technology and fertility treatment led him to pursue his training locally and in National University of Singapore. He qualified with postgraduate Diploma in Reproductive Medicine from the National Population & Family Development Board, Malaysia (LPPKN) in collaboration with Johns Hopkins’ Programme for international Education in O&G, Bachelor of Science in Computing (Hons) from University of Portsmouth, UK and Master of Business Administration from University Tunku Abdul Rahman, Malaysia.
He is one of the pioneer fertility specialists in Malaysia and established Metro IVF Centre in Klang in 1999 and the first IVF pregnancy was delivered in 2000. In 2008, Dr. Tee is one of the key initiators for IVF collaboration between private and public health institutions including Hospital Tengku Ampuan Rahimah, (Metro HTAR IVF Shared Care Programme) and with UiTM (Metro UiTM Private Specialist Centre IVF Shared Care Programme).
With over 20 years of experience in IVF, Dr. Tee has led Metro IVF and it’s group of medical professionals in achieving internationally recognised success rates. The group has since expanded to 7 branches nationwide and was publicly listed in February 2018 on Bursa Malaysia.
Dr. Tee is presently the fertility specialist at Metro IVF and clinical assistant professor at Faculty of Health Science & Medicine at University of Tunku Abdul Rahman (UTAR) and also the treasure and president elect of the Malaysian Society for Assisted Reproductive Technology (MSART).
Dr. Tee SP graduated from University of Malaya with Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1982. He then performed his specialization training in O&G at Seremban General Hospital, University Kebangsaan Malaysia and finally at John Radcliffe Hospital, University of Oxford and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 1989 and later as a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG).
His passion in assisted reproductive technology and fertility treatment led him to pursue his training locally and in National University of Singapore. He qualified with postgraduate Diploma in Reproductive Medicine from the National Population & Family Development Board, Malaysia (LPPKN) in collaboration with Johns Hopkins’ Programme for international Education in O&G, Bachelor of Science in Computing (Hons) from University of Portsmouth, UK and Master of Business Administration from University Tunku Abdul Rahman, Malaysia.
He is one of the pioneer fertility specialists in Malaysia and established Metro IVF Centre in Klang in 1999 and the first IVF pregnancy was delivered in 2000. In 2008, Dr. Tee is one of the key initiators for IVF collaboration between private and public health institutions including Hospital Tengku Ampuan Rahimah, (Metro HTAR IVF Shared Care Programme) and with UiTM (Metro UiTM Private Specialist Centre IVF Shared Care Programme).
With over 20 years of experience in IVF, Dr. Tee has led Metro IVF and it’s group of medical professionals in achieving internationally recognised success rates. The group has since expanded to 7 branches nationwide and was publicly listed in February 2018 on Bursa Malaysia.
Dr. Tee is presently the fertility specialist at Metro IVF and clinical assistant professor at Faculty of Health Science & Medicine at University of Tunku Abdul Rahman (UTAR) and also the treasure and president elect of the Malaysian Society for Assisted Reproductive Technology (MSART).



Ovulation Induction
In a normal unstimulated menstrual cycle, around 30 primordial follicles will be recruited and stimulated to grow. However, only one of the follicles will eventually become dominant and develop into a Graafian follicle. While the dominant follicle develops into a Graafian follicle, it will suppress the growth of other follicles and subsequently cause them to degenerate. Thus, during a normal menstrual cycle, only one egg will become a fully mature Graafian follicle. When the maturing Graffian follicle reaches 16 mm in size, there will be a rise in LH hormone release which triggers ovulation at mid-cycle.
In a stimulated ovarian-induction cycle, fertility drugs are used to stimulate the ovaries to enhance the growth and maturation of multiple follicles and yield more eggs of better quality. Therefore, several follicles will develop into mature Graafian follicles at the same time and ovulate at the mid-cycle.
There are two basic types of medication that are used to induce ovulation. Treatment with these drugs has the potential to result in pregnancy if the woman has good quality and quantity of eggs in her ovaries, and if other causes of infertility are not present.
Ovarian Stimulation using Clomiphene for IUI or time intercourse
This is a simple treatment whereby the ovaries are stimulated with oral drugs (clomiphene citrate) to produce 2 to 3 eggs and allow fertilization to occur at timed intercourse. This is the best choice of treatment for those with uncomplicated hormonal disorders and PCOS (polycystic ovarian syndrome).
In this treatment, clomiphene citrate is given daily from Day 3 to Day 7. Follicular tracking by transvaginal scan is done to monitor the growth of follicles from Day 12 of menses and every 2 days until follicles are mature. The mature follicle is defined as a follicle that reaches the size of 17- 18mm. When the follicles mature, the treated couple is advised to have timed intercourse or IUI is performed. After two weeks, a urine or serum pregnancy test will be carried out to confirm the pregnancy.
.png)
Ovarian stimulation using Injectable FSH for IVF (Controlled Ovarian Hyperstimulation)
Injectable medication used for stimulating the ovaries is a follicle-stimulating hormone (FSH). FSH is more potent than Clomiphene and will cause many more eggs to grow and mature. The aim is to produce 5 to 15 mature eggs for the IVF cycle. It’s also known as Controlled Ovarian Hyperstimulation (COH). When the follicles have reached the optimum size of 17 mm, HCG injection is given to trigger ovulation.
There are three protocols for COH that are used to produce many quality eggs during IVF treatment, namely:
-
long protocol
-
short protocol
-
antagonist protocol
The option of the protocol is determined by IVF Specialist and depends on the female’s age, hormone levels and the number of eggs.